Busemann Sokole E - Search Results

1

Dosimetry of iodine-123 iomazenil in humans.

Verhoeff NP, Busemann Sokole E, Hengst D, Stubbs JB, van Royen EA. Verhoeff NP, et al. Among authors: busemann sokole e. Eur J Nucl Med. 1993 Jul;20(7):580-4. doi: 10.1007/BF00176551. Eur J Nucl Med. 1993. PMID: 8370378

2

Quantification of central benzodiazepine receptor binding potential in the brain with 123I-iomazenil SPECT: technical and interobserver variability.

Verhoeff NP, Erbas B, Kapucu O, Busemann Sokole E, Blok H, Van Royen EA. Verhoeff NP, et al. Among authors: busemann sokole e. Nucl Med Commun. 1993 Aug;14(8):634-43. doi: 10.1097/00006231-199308000-00003. Nucl Med Commun. 1993. PMID: 8396758

3

Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.

Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Booij J, et al. Among authors: busemann sokole e. Eur J Nucl Med. 1998 Jan;25(1):24-30. Eur J Nucl Med. 1998. PMID: 9396871 Clinical Trial.

4

Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.

Rijks LJ, Busemann Sokole E, Stabin MG, de Bruin K, Janssen AG, van Royen EA. Rijks LJ, et al. Among authors: busemann sokole e. Eur J Nucl Med. 1998 Jan;25(1):40-7. doi: 10.1007/s002590050192. Eur J Nucl Med. 1998. PMID: 9396873 Clinical Trial.

5

Biodistribution and radiation dosimetry of 99mTc-HMPAO-labeled monocytes in patients with rheumatoid arthritis.

Bennink RJ, Thurlings RM, van Hemert FJ, Voermans C, Dohmen SE, van Eck-Smit BL, Tak PP, Busemann-Sokole E. Bennink RJ, et al. Among authors: busemann sokole e. J Nucl Med. 2008 Aug;49(8):1380-5. doi: 10.2967/jnumed.108.051755. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632808 Free article.

6

Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study.

Verberne HJ, Feenstra C, de Jong WM, Somsen GA, van Eck-Smit BL, Busemann Sokole E. Verberne HJ, et al. Among authors: busemann sokole e. Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1100-7. doi: 10.1007/s00259-005-1810-3. Epub 2005 May 18. Eur J Nucl Med Mol Imaging. 2005. PMID: 15902438

7

Experience with gated cardiac software phantoms for quality control of applications programmes.

Busemann Sokole E, Cradduck TD, Erickson JJ. Busemann Sokole E, et al. Eur J Nucl Med. 1990;17(3-4):106-10. doi: 10.1007/BF00811435. Eur J Nucl Med. 1990. PMID: 2279489

8

Acceptance testing for nuclear medicine instrumentation.

Busemann Sokole E, Płachcínska A, Britten A; EANM Physics Committee. Busemann Sokole E, et al. Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):672-81. doi: 10.1007/s00259-009-1348-x. Eur J Nucl Med Mol Imaging. 2010. PMID: 20135120 No abstract available.

9

Radiopharmaceutical management of 90Y/111In labeled antibodies: shielding and quantification during preparation and administration.

van Hemert FJ, Sloof GW, Schimmel KJ, Vervenne WL, van Eck-Smrr BL, Busemann-Sokole E. van Hemert FJ, et al. Among authors: busemann sokole e. Ann Nucl Med. 2006 Oct;20(8):575-81. doi: 10.1007/BF03026825. Ann Nucl Med. 2006. PMID: 17134028

10

Evaluation of high-resolution pinhole SPECT using a small rotating animal.

Habraken JB, de Bruin K, Shehata M, Booij J, Bennink R, van Eck Smit BL, Busemann Sokole E. Habraken JB, et al. Among authors: busemann sokole e. J Nucl Med. 2001 Dec;42(12):1863-9. J Nucl Med. 2001. PMID: 11752086 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page